Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Globus Medical nets $23.3mm via IPO

Executive Summary

Globus Medical Inc. (develops medical devices for spinal disorders) netted $23.3mm through its initial public offering of 2.08mm Class A common shares priced at $12. Selling shareholders offered another 6.25mm. The company, which filed for the IPO in March, had announced plans to sell shares between $16 and $18. Just prior to going public, Globus’ board approved a 1-for-3.25 reverse split of its common stock.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies